TransCode Therapeutics, Inc. (RNAZ)
$2.70-5.92%Close
SELLCRISIS · day 23
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $3M
- Avg volume
- 48.3K
- Beta
- 1.24
- P/E (TTM)
- -0.05
- Short % float
- 3.26%
- Days to cover
- 1.8
- SI change
- -18.0%
- 1W
- -14.56%
- 1M
- -54.47%
- 3M
- -56.73%
- YTD
- -63.51%
- vs SPY 1W
- -13.37%
- vs SPY 1M
- -57.79%
- vs SPY 3M
- -59.12%
- vs SPY YTD
- -75.27%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- BDSXBUYBiodesix, Inc.RECOVERYQ -9$25.39-4.66%
- ESPRBUYEsperion Therapeutics, Inc.BULLQ 1$3.18+0.00%
- LXRXSELLLexicon Pharmaceuticals, Inc.BEARQ 6$2.32+0.87%
- CANFSELLCan-Fite BioPharma Ltd.RECOVERYQ -14$3.35+0.60%
- INNVSELLInnovAge Holding Corp.BEARQ 14$11.02+0.55%
- BCTXBUYBriaCell Therapeutics Corp.RECOVERYQ -17$3.46-14.99%
- EUDASELLEUDA Health Holdings LimitedCRISISQ -9$15.40+16.58%
- PPCBSELLPropanc Biopharma, Inc.CRISISQ -15$1.16+7.41%
- HYFTBUYMindWalk Holdings Corp.RECOVERYQ 8$1.38-2.13%
- ANLBUYAdlai Nortye Ltd.RECOVERYQ 14$14.16+3.36%
- NXGLSELLNEXGEL, Inc.CRISISQ -13$0.38+15.15%
- EBSSELLEmergent BioSolutions Inc.CRISISQ 12$5.18+1.97%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 0
- GROWTH
- 31
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-34.8%
REV YoY-
ROE-58.1%
EPS YoY-
ROA-28.3%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.05
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B0.02
P/FCF-
EV/EBITDA182.71
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E471.54
ALTMAN Z-
CURR RATIO0.00
ND/EBITDA-
BETA1.24
